Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Acta Biomater. 2014 Sep 22;11:393–403. doi: 10.1016/j.actbio.2014.09.020

Figure 7.

Figure 7

DNA transfection efficacy and relative metabolic activity of MAu/DNA/siRNA LbL nanoparticles. Lipofectamine® 2000 was added at a 100 ng (2.5:1) dose and is not statistically different from nanoparticle formulation HD5. Lipofectamine® 2000’s expression was statistically significantly greater than all other formulations (p-value < 0.0001).